Cite
HARVARD Citation
Sui, C. et al. (2019). LncRNA FOXD2‐AS1 as a competitive endogenous RNA against miR‐150‐5p reverses resistance to sorafenib in hepatocellular carcinoma. Journal of cellular and molecular medicine. 23 (9), pp. 6024-6033. [Online].